The Centers for Medicare & Medicaid Services has issued a request for information regarding the possibility of instituting a director provider contract model. CMS will accept comments through May 25.
GlyCylic®’s vehicle (glycolic acid) works to break the bonds between the outer layers of the wart, including dead skin cells, and open pathways for the Salicylic Acid to achieve deep penetration.
GlyCylic® - is the first wart remover formulated with salicylic acid (a beta-hydroxy acid), glycolic acid (an alpha-hydroxyl acid), and immunomodulatory, virucidal, anti-scarring, and antiseptic ingredients that condition the emerging skin and promote healing while minimizing swelling, irritation, inflammation, and scarring.
A recent randomized trial found that patients rated physicians lower in terms of communication skills and compassion when they used and electronic medical record during an office visit rather than a notepad.
Focusing on adopting a team-based approach and taking advantage of all the tools that are available can help small practices cope under the Merit-based Incentive Payment System.
Editor’s note: check out APMA’s MIPS Member FAQs for all you need to know about the program.
Are you and your patients missing out on the benefits of laser therapy? Check out the eBook to discover the six most common conditions you should be treating with laser therapy and take your practice to the next level.
Podiatrists deserve better than one-size-fits-all software. Get paid fully, quickly and fairly with ABILITY. Use our secure web-based tool to connect with thousands of payers. Check eligibility and correct claim errors on the spot. Fast set-up – nothing to install.
View our no-cost on-demand webinar!
In a letter to Seema Verma, administrator of the Centers for Medicare & Medicaid Services, nearly 50 physician groups called for the agency to reduce the 2018 reporting period for MIPS to 90 days.